Southern Acids (M) Bhd
KLSE:SAB
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3.09
3.71
|
Price Target |
|
We'll email you a reminder when the closing price reaches MYR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one SAB stock under the Base Case scenario is 3.41 MYR. Compared to the current market price of 3.1 MYR, Southern Acids (M) Bhd is Undervalued by 9%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Southern Acids (M) Bhd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for SAB cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Southern Acids (M) Bhd
Balance Sheet Decomposition
Southern Acids (M) Bhd
Current Assets | 612.7m |
Cash & Short-Term Investments | 580.4m |
Receivables | 117.4m |
Other Current Assets | -85.1m |
Non-Current Assets | 406.2m |
Long-Term Investments | 191.7m |
PP&E | 212.5m |
Other Non-Current Assets | 2m |
Current Liabilities | 102.7m |
Accounts Payable | 31.6m |
Other Current Liabilities | 71m |
Non-Current Liabilities | 136.7m |
Long-Term Debt | 2.1m |
Other Non-Current Liabilities | 134.6m |
Earnings Waterfall
Southern Acids (M) Bhd
Revenue
|
933.7m
MYR
|
Cost of Revenue
|
-837.1m
MYR
|
Gross Profit
|
96.6m
MYR
|
Operating Expenses
|
-61.2m
MYR
|
Operating Income
|
35.4m
MYR
|
Other Expenses
|
-29.2m
MYR
|
Net Income
|
6.2m
MYR
|
Free Cash Flow Analysis
Southern Acids (M) Bhd
MYR | |
Free Cash Flow | MYR |
SAB Profitability Score
Profitability Due Diligence
Southern Acids (M) Bhd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
Score
Southern Acids (M) Bhd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
SAB Solvency Score
Solvency Due Diligence
Southern Acids (M) Bhd's solvency score is 91/100. The higher the solvency score, the more solvent the company is.
Score
Southern Acids (M) Bhd's solvency score is 91/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SAB Price Targets Summary
Southern Acids (M) Bhd
Dividends
Current shareholder yield for SAB is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Southern Acids (Malaysia) Bhd.is an investment holding company, which engages in the provision of management services to its subsidiaries. The company is headquartered in Klang, Selangor and currently employs 1,671 full-time employees. The firm's segments include Oleochemical segment, Milling & Estate segment and Healthcare segment. The Oleochemical segment is involved in manufacturing and marketing of fatty acids and glycerin. The Oleochemical segment offers its products to end- use applications, such as personal care, cleaning agents and food products. The Milling & Estate segment is engaged in processing of Fresh Fruit Bunches (FFB) into crude palm oil and oil palm cultivation. The Healthcare segment operates in the private healthcare space. The firm's subsidiaries include Southern Acids (M) Berhad Sdn. Bhd., Southern Acids Industries Sdn. Bhd., PKE Transport (Malaysia) Sdn. Bhd., Pembinaan Gejati Sdn. Bhd, Sab Properties Development Co. Sdn. Berhad, Noble Interest Sdn. Bhd., Southern Medicare Sdn. Bhd., Wilstar Sdn. Bhd, SAB Plantation Sdn. Bhd and Firstview Development Sdn. Bhd.
Contact
IPO
Employees
Officers
The intrinsic value of one SAB stock under the Base Case scenario is 3.41 MYR.
Compared to the current market price of 3.1 MYR, Southern Acids (M) Bhd is Undervalued by 9%.